Xiangdong Xue, Ph.D., Associate Professor, Principal Investigator at School of Pharmacy, Shanghai Jiao Tong University. Dr. Xue got Ph.D. degree from the National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, under the supervision of Professor Xing-Jie Liang. Then, he started his postdoctoral career in the United States. From 2015 to 2020, Dr. Xue worked as a postdoctoral researcher at the Washington University in St. Louis and the University of California, Davis. Dr. Xue is devoted to developing intelligent nanomedicine for precise diagnosis and effective therapy of different cancers. Then, he joined Shanghai Jiao Tong University as a full-time faculty in Dec. 2020. At present, Dr. Xue has published 46 high-level SCI papers, and his publications have been cited more than 2600 times, with an H factor of 25. As the first or corresponding author, Dr. Xue has published 17 papers (total IF >210) in some decent journals, such as Nature Nanotechnology, Nature Communications, Advanced Materials, ACS Nano, Biomaterials, Advanced Functional Materials, Advanced Science, Journal of Controlled Release, Nano Research. Dr. Xue has applied for 2 PCT international patents and 5 Chinese patents. Meanwhile, Dr. Xue has been recognized by the peers, he has been invited as reviewer of ~20 peer-reviewed journals, including Biomaterials, Advanced Sciences, Small, ACS Applied Material & Interface, Chemical Engineering Journal, Acta Biomaterialia, Journal of Controlled Release, Molecular Pharmaceutics.

Xue lab is newly established, so we are recruiting. Come and join us, we welcome scientists from different fields who are interested in combating cancer with advanced chemical, material, medicinal and biological technologies.